Valuation: Viatris Inc.

Capitalization 12.89B 11.07B 10.39B 9.68B 17.83B 1,158B 19.37B 120B 46.82B 549B 48.36B 47.34B 2,022B P/E ratio 2025 *
-4.29x
P/E ratio 2026 * 84x
Enterprise value 25.72B 22.1B 20.73B 19.32B 35.57B 2,311B 38.66B 240B 93.43B 1,095B 96.51B 94.46B 4,035B EV / Sales 2025 *
1.82x
EV / Sales 2026 * 1.71x
Free-Float
96.32%
Yield 2025 *
4.3%
Yield 2026 * 4.57%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.90%
1 week+4.48%
Current month+4.68%
1 month+10.57%
3 months+7.08%
6 months+27.01%
Current year-10.12%
More quotes
1 week 10.67
Extreme 10.67
11.32
1 month 10.15
Extreme 10.15
11.32
Current year 6.85
Extreme 6.85
12.6
1 year 6.85
Extreme 6.85
13.13
3 years 6.85
Extreme 6.85
13.62
5 years 6.85
Extreme 6.85
18.86
10 years 6.85
Extreme 6.85
55.5
More quotes
Manager TitleAgeSince
Chief Executive Officer 62 2023-03-31
Director of Finance/CFO 42 2023-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 77 2020-11-15
Director/Board Member 77 2020-11-15
Director/Board Member 61 2020-11-15
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.90%+4.48%-12.58%+3.80% 12.77B
-1.54%-6.11%+22.23%+172.09% 893B
-0.82%-2.66%+33.66%+13.78% 486B
-0.06%-0.62%+26.29%+36.75% 394B
-0.76%+0.64%+22.59%+3.51% 336B
+0.10%-1.51%+27.00%+19.71% 280B
+0.17%+0.58%+19.51%+24.96% 253B
-2.06%-4.10%-6.65%-10.93% 246B
+0.07%-2.56%-61.75%-35.08% 207B
-2.30%-7.24%+13.05%+12.63% 173B
Average -0.76%-1.76%+8.34%+24.12% 328.11B
Weighted average by Cap. -1.05%-2.78%+16.57%+54.93%
See all sector performances

Financials

2025 *2026 *
Net sales 14.1B 12.11B 11.36B 10.59B 19.5B 1,267B 21.19B 132B 51.22B 600B 52.9B 51.78B 2,212B 14.28B 12.27B 11.51B 10.72B 19.75B 1,283B 21.46B 133B 51.87B 608B 53.58B 52.44B 2,240B
Net income -3.21B -2.76B -2.59B -2.41B -4.44B -288B -4.83B -30.01B -11.66B -137B -12.05B -11.79B -504B 86.37M 74.21M 69.62M 64.87M 119M 7.76B 130M 807M 314M 3.68B 324M 317M 13.55B
Net Debt 12.83B 11.02B 10.34B 9.64B 17.75B 1,153B 19.28B 120B 46.61B 546B 48.14B 47.12B 2,013B 11.53B 9.91B 9.3B 8.66B 15.95B 1,036B 17.34B 108B 41.9B 491B 43.28B 42.37B 1,810B
More financial data * Estimated data
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s ARV franchise. The Company’s portfolio comprises approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands and generics, including complex products. The Company operates manufacturing sites across worldwide that produce oral solid doses, injectables and complex dosage forms.
Employees
30,000
More about the company
Date Price Change Volume
25-12-09 11.19 $ +0.90% 10,149,988
25-12-08 11.09 $ +1.46% 9,337,260
25-12-05 10.93 $ +1.58% 5,855,860
25-12-04 10.76 $ -0.74% 5,229,391
25-12-03 10.84 $ +1.21% 5,616,514

Delayed Quote Nasdaq, December 09, 2025 at 04:00 pm EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
11.19USD
Average target price
12.44USD
Spread / Average Target
+11.21%
Consensus

Quarterly revenue - Rate of surprise